Adjuvanted and high-dose influenza vaccines had comparable effectiveness against test-confirmed influenza outcomes including hospitalizations in overall and high-risk older adults in the 2022–2023 and 2023–2024 seasons

International Journal of Infectious Diseases · Published 2026-08-01 · DOI 10.1016/j.ijid.2026.109025

Free full text

Authors (7)

Mahrukh Imran, Benjamin Chastek, Tim Bancroft, Noah Webb, Stephen I. Pelton, Mendel D.M. Haag, Ian McGovern

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Imran, M., Chastek, B., Bancroft, T., et al. (2026). Adjuvanted and high-dose influenza vaccines had comparable effectiveness against test-confirmed influenza outcomes including hospitalizations in overall and high-risk older adults in the 2022–2023 and 2023–2024 seasons. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2026.109025

Related articles